P-glycoprotein Expression in Treated and Untreated Human Breast Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1989 Dec 1

PMID 2574987

Citations 37

Authors

J Schneider

M Bak

T Efferth

M Kaufmann

J Mattern

M Volm

Affiliations

Soon will be listed here.

Abstract

The expression of P-glycoprotein in primary and recurrent human breast cancer was investigated by means of immunohistochemistry, using a monoclonal antibody (C219) and the streptavidin-biotin-peroxidase method. Twelve patients received no chemotherapeutic treatment. The other 11 patients were treated with chemotherapy, and all developed clinical resistance to it. No or only minimal reactivity was found in specimens coming from the untreated patients (12 cases) or from patients treated with substances not involved in the multidrug resistance phenomenon (four cases). In contrast, three out of seven tumours from patients treated with multidrug resistance related substances showed clear reactivity (positive staining in more than 20% of the tumour cells). In one of these cases, where specimens of the tumour could be studied before and after treatment, an association between the latter and expression of P-glycoprotein was suggested. Finally, this marked expression of P-glycoprotein only took place in tumours treated over a longer space of time (five courses or more of multidrug resistance related chemotherapy).

Citing Articles

The Evolution and Ecology of Resistance in Cancer Therapy.

Gatenby R, Brown J Cold Spring Harb Perspect Med. 2020; 10(11).

PMID: 33139405 PMC: 7605238. DOI: 10.1101/cshperspect.a040972.

P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy-a Prospective Clinical Study from a Developing Country.

Mehrotra M, Anand A, Singh K, Kumar S, Husain N, Sonkar A Indian J Surg Oncol. 2018; 9(4):524-529.

PMID: 30538383 PMC: 6265170. DOI: 10.1007/s13193-018-0797-8.

The Evolution and Ecology of Resistance in Cancer Therapy.

Gatenby R, Brown J Cold Spring Harb Perspect Med. 2017; 8(3).

PMID: 28710258 PMC: 5830903. DOI: 10.1101/cshperspect.a033415.

Application of Evolutionary Principles to Cancer Therapy.

Enriquez-Navas P, Wojtkowiak J, Gatenby R Cancer Res. 2015; 75(22):4675-80.

PMID: 26527288 PMC: 4693617. DOI: 10.1158/0008-5472.CAN-15-1337.

Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".

Kam Y, Das T, Tian H, Foroutan P, Ruiz E, Martinez G Int J Cancer. 2014; 136(4):E188-96.

PMID: 25156304 PMC: 4262548. DOI: 10.1002/ijc.29158.

References

Juliano R, Ling V . A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976; 455(1):152-62. DOI: 10.1016/0005-2736(76)90160-7. View

Volm M, Efferth T, Bak M, Ho A, Mattern J . Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol. 1989; 25(4):743-9. DOI: 10.1016/0277-5379(89)90213-7. View

Bell D, Gerlach J, Kartner N, Buick R, Ling V . Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol. 1985; 3(3):311-5. DOI: 10.1200/JCO.1985.3.3.311. View

Kartner N, Bradley G, Ling V . Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 1985; 316(6031):820-3. DOI: 10.1038/316820a0. View

Thiebaut F, Tsuruo T, Hamada H, Gottesman M, Pastan I, Willingham M . Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987; 84(21):7735-8. PMC: 299375. DOI: 10.1073/pnas.84.21.7735. View

Volm M, Efferth T, Gunther A, Lathan B . Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody. Arzneimittelforschung. 1987; 37(7):862-7. View

Moscow J, Cowan K . Multidrug resistance. J Natl Cancer Inst. 1988; 80(1):14-20. DOI: 10.1093/jnci/80.1.14. View

Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S . Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res. 1988; 48(7):1926-9. View

Tsuruo T . Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res. 1988; 79(3):285-96. PMC: 5917488. DOI: 10.1111/j.1349-7006.1988.tb01588.x. View

10.

Volm M, Bak Jr M, Efferth T, Lathan B, Mattern J . Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res. 1988; 8(4):531-5. View

11.

Chan H, Bradley G, Thorner P, Haddad G, Gallie B, Ling V . A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines. Lab Invest. 1988; 59(6):870-5. View

12.

Ma D, Scurr R, Davey R, Mackertich S, Harman D, Dowden G . Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet. 1987; 1(8525):135-7. DOI: 10.1016/s0140-6736(87)91969-6. View

13.

Goldstein L, Galski H, Fojo A, Willingham M, Lai S, Gazdar A . Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst. 1989; 81(2):116-24. DOI: 10.1093/jnci/81.2.116. View

14.

Volm M, Bak Jr M, Efferth T, Mattern J . Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA-sequences and membrane glycoproteins. Anticancer Res. 1988; 8(6):1169-78. View

15.

Broxterman H, Pinedo H, Kuiper C, van der Hoeven J, de Lange P, Quak J . Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance. Int J Cancer. 1989; 43(2):340-3. DOI: 10.1002/ijc.2910430229. View

16.

Kartner N, Riordan J, Ling V . Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 1983; 221(4617):1285-8. DOI: 10.1126/science.6137059. View